FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2963676864> ?p ?o ?g. }

• W2963676864 endingPage "1787" @default.
• W2963676864 startingPage "1779" @default.
• W2963676864 abstract "Background Most non‐small cell lung cancer (NSCLC) patients relapse on anaplastic lymphoma kinase‐tyrosine kinase inhibitor (ALK‐TKI) therapy because of acquired resistance. Rebiopsy is recommended to provide optimal therapy after relapse for some ALK‐TKI therapies; however, little clinical data exists on the clinical efficacy of ALK‐TKI tailored to secondary mutation. Methods A retrospective study was conducted to analyze the patterns of ALK‐TKI treatment and clinical outcomes, including progression free survival (PFS), of ALK‐positive NSCLC patients who received rebiopsy. Based on the rebiopsy results, secondary mutations in the ALK gene that were shown to be associated with the efficacy of ALK‐TKI therapy in the preclinical or clinical setting were defined as “sensitive mutations (SM)”. Results Among 71 patients who received ALK‐TKI for NSCLC at our institution, 20 patients received rebiopsy, and secondary SM were found in eight patients. The objective response rate (ORR) of the cases with SM who received ALK‐TKI therapy was 88.9%, while the ORR of the patients without SM who received ALK TKI or chemotherapy was 20.0%; however, the PFS of the patients with SM was relatively short (with SM vs. without SM: 5.6 months vs. 5.1 months). Conclusions The selection of ALK‐TKI based on the rebiopsy result was associated with a high ORR and relatively short PFS. The mechanism responsible for the short PFS of sensitive ALK‐TKI to secondary mutation should be clarified." @default.
• W2963676864 created "2019-07-30" @default.
• W2963676864 creator A5001895894 @default.
• W2963676864 creator A5002874553 @default.
• W2963676864 creator A5004273623 @default.
• W2963676864 creator A5009383534 @default.
• W2963676864 creator A5017789799 @default.
• W2963676864 creator A5021568645 @default.
• W2963676864 creator A5025515292 @default.
• W2963676864 creator A5026831952 @default.
• W2963676864 creator A5054118501 @default.
• W2963676864 creator A5067259938 @default.
• W2963676864 creator A5069784331 @default.
• W2963676864 creator A5086171353 @default.
• W2963676864 date "2019-07-23" @default.
• W2963676864 modified "2023-10-04" @default.
• W2963676864 title "Short progression‐free survival of ALK inhibitors sensitive to secondary mutations in ALK‐positive NSCLC patients" @default.
• W2963676864 cites W1552707386 @default.
• W2963676864 cites W1969391810 @default.
• W2963676864 cites W2050249255 @default.
• W2963676864 cites W2063231856 @default.
• W2963676864 cites W2113327188 @default.
• W2963676864 cites W2123394258 @default.
• W2963676864 cites W2125735484 @default.
• W2963676864 cites W2133422931 @default.
• W2963676864 cites W2205667543 @default.
• W2963676864 cites W2226979499 @default.
• W2963676864 cites W2482427906 @default.
• W2963676864 cites W2506630723 @default.
• W2963676864 cites W2533300620 @default.
• W2963676864 cites W2537179917 @default.
• W2963676864 cites W2551769647 @default.
• W2963676864 cites W2560284840 @default.
• W2963676864 cites W2581592505 @default.
• W2963676864 cites W2610816290 @default.
• W2963676864 cites W2613260339 @default.
• W2963676864 cites W2623725180 @default.
• W2963676864 cites W2624310346 @default.
• W2963676864 cites W2767072667 @default.
• W2963676864 cites W2785110924 @default.
• W2963676864 cites W2796631032 @default.
• W2963676864 cites W2797685139 @default.
• W2963676864 cites W2809495979 @default.
• W2963676864 cites W2888359589 @default.
• W2963676864 cites W2899668190 @default.
• W2963676864 cites W2923683745 @default.
• W2963676864 doi "https://doi.org/10.1111/1759-7714.13143" @default.
• W2963676864 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6718030" @default.
• W2963676864 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31338990" @default.
• W2963676864 hasPublicationYear "2019" @default.
• W2963676864 type Work @default.
• W2963676864 sameAs 2963676864 @default.
• W2963676864 citedByCount "7" @default.
• W2963676864 countsByYear W29636768642020 @default.
• W2963676864 countsByYear W29636768642021 @default.
• W2963676864 countsByYear W29636768642022 @default.
• W2963676864 countsByYear W29636768642023 @default.
• W2963676864 crossrefType "journal-article" @default.
• W2963676864 hasAuthorship W2963676864A5001895894 @default.
• W2963676864 hasAuthorship W2963676864A5002874553 @default.
• W2963676864 hasAuthorship W2963676864A5004273623 @default.
• W2963676864 hasAuthorship W2963676864A5009383534 @default.
• W2963676864 hasAuthorship W2963676864A5017789799 @default.
• W2963676864 hasAuthorship W2963676864A5021568645 @default.
• W2963676864 hasAuthorship W2963676864A5025515292 @default.
• W2963676864 hasAuthorship W2963676864A5026831952 @default.
• W2963676864 hasAuthorship W2963676864A5054118501 @default.
• W2963676864 hasAuthorship W2963676864A5067259938 @default.
• W2963676864 hasAuthorship W2963676864A5069784331 @default.
• W2963676864 hasAuthorship W2963676864A5086171353 @default.
• W2963676864 hasBestOaLocation W29636768641 @default.
• W2963676864 hasConcept C117643217 @default.
• W2963676864 hasConcept C126322002 @default.
• W2963676864 hasConcept C143998085 @default.
• W2963676864 hasConcept C2776232967 @default.
• W2963676864 hasConcept C2776256026 @default.
• W2963676864 hasConcept C2776694085 @default.
• W2963676864 hasConcept C2778347629 @default.
• W2963676864 hasConcept C2779422266 @default.
• W2963676864 hasConcept C2780739268 @default.
• W2963676864 hasConcept C71924100 @default.
• W2963676864 hasConceptScore W2963676864C117643217 @default.
• W2963676864 hasConceptScore W2963676864C126322002 @default.
• W2963676864 hasConceptScore W2963676864C143998085 @default.
• W2963676864 hasConceptScore W2963676864C2776232967 @default.
• W2963676864 hasConceptScore W2963676864C2776256026 @default.
• W2963676864 hasConceptScore W2963676864C2776694085 @default.
• W2963676864 hasConceptScore W2963676864C2778347629 @default.
• W2963676864 hasConceptScore W2963676864C2779422266 @default.
• W2963676864 hasConceptScore W2963676864C2780739268 @default.
• W2963676864 hasConceptScore W2963676864C71924100 @default.
• W2963676864 hasIssue "9" @default.
• W2963676864 hasLocation W29636768641 @default.
• W2963676864 hasLocation W29636768642 @default.
• W2963676864 hasLocation W29636768643 @default.
• W2963676864 hasLocation W29636768644 @default.
• W2963676864 hasOpenAccess W2963676864 @default.
• W2963676864 hasPrimaryLocation W29636768641 @default.

• next